Armored Likho BusySnake Stealer, a Python-based infostealer first disclosed by Kaspersky, is actively targeting government ...

The former majority owner of TikTok has quietly continued to court filmmakers, independent artists and executives who are ...

The AI-assisted editor now works alongside the platform's MCP server and interactive documentation, giving developers plain-language code generation, debugging, and reference lookup across a single ...

Addressing the pervasive challenges within the software development lifecycle (SDLC), such as poorly defined requirements, ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

Abstract: Large language models (LLMs) are increasingly being used in various domains, including chip design. Recent works have demonstrated the effectiveness of LLMs in EDA tool script generation.

Discover the top 12 tools in 2026, from Cursor to Copilot, to speed up daily dev workflows and build apps faster!

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...